GP

Ganeshprasad Poorigali Pattabhiramaiah

Director Director DIN 02292857
DIN 02292857 First appointment Nov 2008 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Nov 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganeshprasad Poorigali Pattabhiramaiah

Data last updated:

Ganeshprasad Poorigali Pattabhiramaiah was a Director at Canvet Pharma Incorporation Private Limited (2008–2010). The company operates in Chemicals.

DIN 02292857
Primary Designation Director
Industry Chemicals
First Appointment 20 Nov 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20081995₹29.2 Lakh (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Canvet Pharma Incorporation Private Limited
Premium access

Shareholding and investment profile for Ganeshprasad Poorigali Pattabhiramaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganeshprasad Poorigali Pattabhiramaiah

Ganeshprasad Poorigali Pattabhiramaiah was first appointed on 20 Nov 2008 as Director at Canvet Pharma Incorporation Private Limited.

Ganeshprasad Poorigali Pattabhiramaiah held 1 earlier board appointment: Canvet Pharma Incorporation Private Limited (Director, 20 Nov 2008 to 06 Jan 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available